From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents

被引：0
|
作者：
Caprio, Massimiliano [1 ,2 ]
Vitale, Cristiana [3 ]
Rosano, Giuseppe M. C. [3 ]
机构：
[1] IRCCS San Raffaele Pisana, Lab Cardiovasc Endocrinol, Rome, Italy
[2] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy
[3] IRCCS San Raffaele, Dept Cardiovasc & Resp Sci, Rome, Italy
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2021年 / 7卷 / 02期
关键词：
ACUTE MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; INSULIN-GLUCOSE; MORTALITY; LIRAGLUTIDE; PREVALENCE; OUTCOMES; RISK;
D O I：
10.1093/ehjcvp/pvaa019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 85
页数：3
相关论文
共 50 条
  • [21] Lipid Effects and Cardiovascular Disease Risk Associated with Glucose-Lowering Medications
    Staehli, Barbara E.
    Gebhard, Catherine
    Tardif, Jean-Claude
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (07)
  • [22] Cardiovascular Effects of Noninsulin, Glucose-Lowering Agents: Need for More Outcomes Data
    Joshi, Parag H.
    Kalyani, Rita R.
    Blumenthal, Roger S.
    Donner, Thomas W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (09): : 32B - 42B
  • [23] Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ferrannini, Ele
    DeFronzo, Ralph A.
    EUROPEAN HEART JOURNAL, 2015, 36 (34) : 2288 - U19
  • [24] A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven Safety
    Fitchett, David
    Cheng, Alice
    Connelly, Kim
    Goldenberg, Ronald
    Goodman, Shaun G.
    Leiter, Lawrence A.
    Lonn, Eva
    Paty, Breay
    Poirier, Paul
    Stone, James
    Thompson, David
    Yale, Jean-Francois
    Mancini, G. B. John
    CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (07) : 940 - 942
  • [25] Lipid Effects and Cardiovascular Disease Risk Associated with Glucose-Lowering Medications
    Barbara E. Stähli
    Catherine Gebhard
    Jean-Claude Tardif
    Current Cardiology Reports, 2015, 17
  • [26] Diabetes, bone and glucose-lowering agents: basic biology
    Lecka-Czernik, Beata
    DIABETOLOGIA, 2017, 60 (07) : 1163 - 1169
  • [27] Diabetes, bone and glucose-lowering agents: basic biology
    Beata Lecka-Czernik
    Diabetologia, 2017, 60 : 1163 - 1169
  • [28] Diabetes, bone and glucose-lowering agents: clinical outcomes
    Ann V. Schwartz
    Diabetologia, 2017, 60 : 1170 - 1179
  • [29] Diabetes, bone and glucose-lowering agents: clinical outcomes
    Schwartz, Ann V.
    DIABETOLOGIA, 2017, 60 (07) : 1170 - 1179
  • [30] Is it possible to reduce cardiovascular risk with glucose-lowering approaches?
    Gerstein, Hertzel C.
    NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (05) : 270 - 275
12345